BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

January 08, 2024 | News

AstraZeneca Acquires Gracell, Expanding Cell Therapy Goals in Oncology and Autoimmune Diseases.

AstraZeneca has entered into a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceuti...

December 28, 2023 | News

Bristol Myers Squibb Acquires Karuna Therapeutics for $14 Billion

KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an Adjunctive Therapy, and First-in-Disease Treatment for Alzheimer’s Di...

December 26, 2023 | News

LTS Secures $4.3M Grant for Contraceptive Microneedle Array Patch Development

Poor access to contraceptives presents a significant burden for women living in LMICs. According to a 2022 study, one in 14 women worldwide who want to use...

December 20, 2023 | News

Biorithm Raises $3.5M in Series A to Advance Global Maternal Care

Biorithm, a global women's health medtech, has closed $3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. Wi...

December 19, 2023 | News

Fosun Pharma's Antimalarial Drug Trial Gets 500 Million Yen Boost from GHIT Fund for Global Accessibility Initiative

The Japan-based Global Health Innovative Technology Fund (GHIT Fund) announced that it will invest approximately US$3.3 million (approximate...

December 15, 2023 | News

Nona Biosciences and Pfizer Strike Global Deal for MSLN-Targeted ADC HBM9033

Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potentia...

December 15, 2023 | News

Gilead Sciences Funds HIV Projects in Asia Pacific with $1.5M

–2023 Gilead Asia Pacific Rainbow Grant Funding Will Support 40 Projects In 2024-2025 To Reduce HIV Stigma And Improve Equity Across Asia Pacific &nd...

November 29, 2023 | News

Viva Biotech Secures Approximately US$ 210 Million Funding

Before, the publicly listed company at the group level had already secured approximately US$ 60 million in convertible bond financing, which will...

November 21, 2023 | News

Micron Biomedical Secures $23.6M to Advance Needle-Free Vaccine Production for Measles Eradication

Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...

November 20, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...

November 16, 2023 | News

Ajinomoto Group Makes Strategic Move into Gene Therapy with $750 Million Acquisition of Forge Biologics, Bolstering Healthcare Portfolio for Exponential Growth

In the Medium-Term ASV Initiatives 2030 Roadmap, announced in February this year, Ajinomoto Co. identified four strategic growth areas including Healthcare...

November 15, 2023 | News

Genome Insight Secures $23 Million in Series B-2 Funding Round

This investment will support Genome Insight’s pursuit of bringing whole-genome based precision diagnostics to routine clinical care. Earlier this yea...

November 03, 2023 | News

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

October 30, 2023 | News

Stay Connected